Table 2 Subgroup analysis confined to post-LT sarcopenia (n = 94)

Sex (Male: Female)

44: 16

28: 6

0.1

Age (years)^a

53.8 ± 8.8

56 ± 9.5

0.58

BMI, before LT (kg/m²)^a

22.9 ± 3.3

25.4 ± 2.9

 < 0.001

BMI, 1 year after LT (cm²/m²)^a

21.7 ± 3.2

23.6 ± 2.5

0.01

BMI, 2 years after LT (cm²/m²)^a

21.9 ± 3.1

23.5 ± 2.5

0.01

LDLT

45 (75)

26 (76.5)

0.87

Underlying malignancy

42 (70)

22 (64.7)

0.6

SMI, before LT (cm²/m²)^a

32.6 ± 5.2

43.7 ± 6.6

 < 0.001

SMI, 1 year after LT (cm²/m²)^a

34 ± 7.2

36.2 ± 8.9

0.2

SMI, 2 years after LT (cm²/m²)^a

34.3 ± 7.1

35.8 ± 6.2

0.32

PTDM

3 (5)

7 (20.6)

0.02

HTN after LT

1 (1.7)

3 (8.8)

0.1

Renal failure

3 (5)

5 (14.7)

0.64

Chronic rejection

1 (1.7)

0

0.45

MELD

17.2 ± 4.7

19.2 ± 5.9

0.08